Evidence map›Paper›PMID 31346545›Full record

ReviewCannabis and cannabinoid research2019

Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease.

Janice T Chua, Donovan A Argueta, Nicholas V DiPatrizio, Csaba P Kovesdy, Nosratola D Vaziri, Kamyar Kalantar-Zadeh, Hamid Moradi

Open access · hybridAbstract readReview
In one paragraph

Review in Cannabis and cannabinoid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The effects of cannabinoids on the kidney.Acta physiologica (Oxford, England) · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Cannabinoid receptor 2 (CBNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Janice T ChuaUniversity of California-Irvine, School of Medicine, Orange, California.
Donovan A ArguetaDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California.
Nicholas V DiPatrizioDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California.
Csaba P KovesdyDivision of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee.
Nosratola D VaziriUniversity of California-Irvine, School of Medicine, Orange, California.
Kamyar Kalantar-ZadehUniversity of California-Irvine, School of Medicine, Orange, California.
Hamid MoradiUniversity of California-Irvine, School of Medicine, Orange, California.
University of California, Irvine · USUniversity of California, Riverside · USUniversity of Tennessee Health Science Center · US

Funding

CSRD VA IK2 CX001043
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute kidney injurychronic kidney diseaseendocannabinoidfibrosisinflammationnephropathy

Identifiers

PMID31346545
PMCPMC6653784
OpenAlexW2916013068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.